Biota Holdings' US subsidiary Biota Inc has announced a collaboration with GlaxoSmithKline (GSK) to develop new drugs against Hepatitis C, using Biota Inc's proprietary Numax technology platform. [ + ]

Monash University researchers have identified an enzyme that is largely responsible for the abnormal blood clotting that underlies heart attack and stroke, offering hope that a drug that effectively prevents these blood clots from forming will be available within 10 years.

A new breed of 'destroyer drug' which only targets diseased cancer cells is in the first stages of development by the Oxfordshire-based biotechnology company Avidex.

Infectious disease detection test developer Cellestis has posted a greater than fourfold jump in revenue to end the full year at $583,000. [ + ]

Perth based medical devices company Xcell Diagnostics has signed a letter of intent to acquire German company Visiomed in a deal that includes a combination of shares, options, cash and royalties. [ + ]

Database company Oracle Corp is enhancing life sciences-oriented data mining and data analysis features in upcoming versions of its flagship database product. [ + ]

DNA databases should not be in the hands of the police, and they should contain DNA profiles of all members of the population, according to Prof Bob Williamson, director of the Murdoch Children's Research Institute. [ + ]

In a step towards improved application of cell therapies, South Australian company BresaGen has gained US Food and Drug Administration approval to market a catheter designed for the delivery of therapeutics to the brain. [ + ]

Recent studies by scientists at ANSTO, have revealed some startling discoveries about what really constitutes the water in our neighbouring oceans.

Chemeq has raised $8 million in its latest placement to institutions and other sophisticated investors, bringing the total raised this year to $15.5 million. [ + ]

Drug delivery group Norwood Abbey has added another patent to its portfolio, the latest covering laser technology to alter the skin's surface. [ + ]

Melbourne researchers have uncovered a new genetic player in programmed cell death, offering a fresh target for potential cancer therapies. [ + ]

A decision by the European Patent Office (EPO) to revise the controversial 'Edinburgh' patent to exclude embryonic stem cells has disappointed Australian company Stem Cell Sciences. [ + ]

A new Sydney imaging centre is set to improve research opportunities for brain and nervous system specialists. [ + ]

Monash University researchers have identified two basic mechanisms that control the level of calcium deposition in bones and joints, a finding that could lead to treatments for osteoporosis and some forms of arthritis.